Sage Therapeutics (SAGE)
(Real Time Quote from BATS)
$12.14 USD
+0.24 (2.02%)
Updated May 13, 2024 01:42 PM ET
3-Hold of 5 3
D Value B Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -1.69 |
EPS Last Quarter | -1.80 |
Last EPS Surprise | -10.43% |
ABR | 2.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.53 |
Next Year | -5.01 |
EPS (TTM) | -7.84 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.04M | 11.26M | 42.16M | 154.93M |
# of Estimates | 11 | 11 | 12 | 12 |
High Estimate | 13.90M | 17.90M | 59.90M | 584.56M |
Low Estimate | 6.78M | 7.48M | 31.89M | 65.71M |
Year ago Sales | 2.47M | 2.72M | 86.46M | 42.16M |
Year over Year Growth Est. | 266.15% | 314.04% | -51.24% | 267.52% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.69 | -1.63 | -6.53 | -5.01 |
# of Estimates | 13 | 11 | 14 | 14 |
Most Recent Consensus | -1.58 | -1.56 | -6.52 | -5.50 |
High Estimate | -1.42 | -1.32 | -5.66 | 3.59 |
Low Estimate | -2.04 | -1.90 | -7.36 | -7.53 |
Year ago EPS | -2.68 | -2.81 | -9.05 | -6.53 |
Year over Year Growth Est. | 36.94% | 41.99% | 27.85% | 23.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 3 | 3 | 4 |
Up Last 60 Days | 3 | 4 | 4 | 6 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 8 | 7 | 10 | 8 |
Down Last 60 Days | 7 | 6 | 9 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.69 | -1.63 | -6.53 | -5.01 |
7 Days Ago | -1.69 | -1.63 | -6.53 | -5.01 |
30 Days Ago | -1.55 | -1.52 | -6.05 | -4.23 |
60 Days Ago | -1.60 | -1.56 | -6.26 | -4.52 |
90 Days Ago | -1.86 | -1.79 | -6.15 | -4.85 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.69 | -1.63 | -6.55 | -5.11 |
Zacks Consensus Estimate | -1.69 | -1.63 | -6.53 | -5.01 |
Earnings ESP | 0.00% | 0.00% | -0.43% | -2.02% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.80 | -0.55 | -2.81 | -2.68 | NA |
Estimate | -1.63 | -1.18 | -2.64 | -2.53 | NA |
Difference | -0.17 | 0.63 | -0.17 | -0.15 | 0.04 |
Surprise | -10.43% | 53.39% | -6.44% | -5.93% | 7.65% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more